Clinical trial
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
NCT03491462 is registered in ClinicalTrials.gov with ZevraDenmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
- Lead sponsor
- ZevraDenmark
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2018
- Completion date
- December 18, 2020
- Enrollment
- 245 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.